Black Diamond Therapeutics, Inc. (BDTX) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.87HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.79HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — BDTX vs CRBP
growth of $100 · dividends reinvested · last 7yBDTX -95.1% (-35.0%/yr)CRBP -97.0% (-39.5%/yr)BDTX compounded faster over this window
BDTX CRBP
BDTX vs CRBP: by the numbers
- •CRBP is the larger company ($107M vs $107M market cap).
- •BDTX is profitable (31.95% net margin) while CRBP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BDTX | CRBP |
|---|---|---|
| P/B ratio | 1.11 | 1.05 |
Profitability
| Metric | BDTX | CRBP |
|---|---|---|
| Gross margin | 99.54% | 0.00% |
| Operating margin | 28.39% | 0.00% |
| Net margin | 31.95% | 0.00% |
| ROE | -44.29% | -99.67% |
| ROIC | -47.54% | -101.30% |
Growth (annualized)
| Metric | BDTX | CRBP |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | -28.32% |
Frequently asked
- Is BDTX or CRBP more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus CRBP at 0.00%.
- How have BDTX and CRBP total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and CRBP delivered -28.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.